(E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide
TL;DR: (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide (CAS 125212-23-9) is a chemical compound with molecular formula C18H15N5O6S and molecular weight 429.07 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
4-[(2-hydroxy-5-nitrophenyl)methylideneamino]-N-(6-methoxypyridazin-3-yl)benzenesulfonamide
Also Known As: (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide, 4-{[(E)-(2-hydroxy-5-nitrophenyl)methylidene]amino}-N-(6-methoxypyridazin-3-yl)benzenesulfonamide, N-(6-methoxypyridazin-3-yl)-4-[(3-nitro-6-oxocyclohexa-2,4-dien-1-ylidene)methylamino]benzenesulfonamide, N-(6-methoxypyridazin-3-yl)-4-[[(E)-(3-nitro-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]benzenesulfonamide
| Molecular Formula | C18H15N5O6S |
|---|---|
| Molecular Weight | 429.07 g/mol |
| LogP | 2.6504 |
| Topological Polar Surface Area | 156.91 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Exact Mass | 429.0743 |
| Heavy Atoms | 30 |
| Complexity | 1194.7416 |
Chemical Identifiers
| CAS Number | 125212-23-9 |
|---|---|
| SMILES | COC1=NN=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N=CC3=C(C=CC(=C3)[N+](=O)[O-])O |
Product Overview
(E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide (CAS 125212-23-9), with molecular formula C18H15N5O6S and molecular weight 429.07 g/mol. IUPAC: 4-[(2-hydroxy-5-nitrophenyl)methylideneamino]-N-(6-methoxypyridazin-3-yl)benzenesulfonamide.
Chemical Property Profile of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide
Property Insights of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide
The XLogP value of 2.6504 suggests moderate lipophilicity, balancing water solubility and membrane permeability for (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide. The TPSA of 156.91 Ų indicates high polarity, suggesting (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide may have limited membrane permeability but good aqueous solubility. Following Lipinski's Rule of Five, (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide has 2 hydrogen bond donor(s) and 9 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide?
The CAS number of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide is 125212-23-9.
What is the molecular formula of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide?
The molecular formula of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide is C18H15N5O6S.
What is the molecular weight of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide?
The molecular weight of (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide is 429.07 g/mol.
Where can I buy (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide?
You can request a quote for (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide?
Yes, KEHONG BIO provides custom synthesis services for (E)-4-((2-hydroxy-5-nitrobenzylidene)amino)-N-(6-methoxypyridazin-3-yl)benzenesulfonamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.